FIELD: medicine.
SUBSTANCE: level of blood bilirubin and total protein is determined by three-point assessment of the total bilirubin level: <60 mcmol/l - 1 point, 60-200 mcmol/l - 2 points, ≥200 mcmol/l - 3 points, total serum protein level: ≥65 g/l - 1 point, 64-55 g/l - 2 points, <55 g/l - 3 points, and disease genesis. In addition, data on the patient's age, presence of diabetes mellitus, concomitant pathology, at that, patient's age, presence of diabetes mellitus and concomitant pathology are assessed on a three-point score: patient's age of 30 to 50 years - 1 point, 50 to 70 years - 2 points, 70 to 90 years - 3 points, diabetes mellitus: no data - 1 point, compensated pathology - 2 points, decompensated pathology - 3 points, concomitant pathology: no data - 1 point, compensated pathology - 2 points, decompensated pathology - 3 points , disease genesis: benign pathology - 0.2 points, malignant pathology: I stage - 0.4 points, II stage - 0.6 points, III stage - 0.8 points, IV stage - 1 point, with the following calculation according to the formula: PD=((Bilirubin+Protein+Age+Diabetes mellitus+ concomitant pathology)×0.33))×(disease genesis×0.2)×100%.
EFFECT: method allows to quickly calculate the course of mechanical jaundice of various genesis, speed up and simplify the diagnosis.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETOXIFICATION IN PATIENTS SUFFERING OBSTRUCTIVE JAUNDICE OF VARIOUS ORIGINS | 2012 |
|
RU2505321C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF OBSTRUCTIVE JAUNDICE OF NON-TUMOR GENESIS | 2019 |
|
RU2703289C1 |
METHOD OF FORMING PRECISION BIHEPATICOJEJUNOANASTOMOSIS AFTER IATROGENIC DAMAGE OF CONFLUENCE OF HEPATIC DUCTS WITHOUT REPLACEABLE TRANSHEPATIC DRAINAGES | 2019 |
|
RU2717893C1 |
METHOD FOR FORMING INTERSTITIAL ANASTOMOSIS | 2017 |
|
RU2663648C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF MECHANICAL JAUNDICE OF MALIGNANT GENESIS | 2020 |
|
RU2738310C1 |
METHOD FOR PREDICTING SEVERE JAUNDICE OF BENIGN GENESIS | 2018 |
|
RU2677468C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PANCREATIC CANCER AND CHRONIC PANCREATITIS | 2018 |
|
RU2714595C1 |
METHOD OF DETERMINING THE AVERAGE RATE OF LIVER FIBROSIS FORMATION IN PATIENTS WITH CHRONIC HEPATITIS B+C | 2022 |
|
RU2801262C1 |
METHOD FOR DETERMINING AVERAGE RATE OF FORMATION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2020 |
|
RU2739687C1 |
METHOD FOR DETERMINING THE AVERAGE RATE OF FORMATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B | 2021 |
|
RU2776039C1 |
Authors
Dates
2017-05-15—Published
2016-01-11—Filed